Mylan receives DCGI approval in India for TB drug, Pretomanid
Pretomanid is only the third new anti-tuberculosis (TB) drug developed specifically for drug-resistant forms of the disease to be…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.